Frontiers in Oncology

Correction

Published on 07 Dec 2023

Corrigendum: Commentary: AI-based online chat and the future of oncology care: a promising technology or a solution in search of a problem?

in Cancer Epidemiology and Prevention

Hui Zhang
Yongfu Guan
Jinping Chen
Wenting Tong

Frontiers in Oncology

doi 10.3389/fonc.2023.1334176

1,027 views
1 citation

Systematic Review

Published on 07 Dec 2023

Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis

in Cancer Genetics

Guangyao Lin
Huicong Liu
Jingyu Lin
Xiyu Liu
Lianwei Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1286610

1,672 views
3 citations

Case Report

Published on 07 Dec 2023

Anlotinib combined with radiotherapy and chemotherapy for recurrent pelvic osteosarcoma treatment: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Qian Chen
Kai Zheng
Ming Xu
Ning Yan
Gong Hai
Xiuchun Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1283932

1,676 views
3 citations

Systematic Review

Published on 07 Dec 2023

Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

in Cancer Immunity and Immunotherapy

Lu Ye
Fei Zhou
Dongdong Cheng
Ming Xie
Xiaoli Yan
Yuyu Xue
Qian Yang
Rong Jia
Lili Zhong
Li Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1240318

5,609 views
6 citations

Original Research

Published on 07 Dec 2023

Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study

in Hematologic Malignancies

Anna Cardellino
Julia R. Correll
Mona Martin
Boris Gorsh
Sandhya Sapra
Rakesh Popat

Frontiers in Oncology

doi 10.3389/fonc.2023.1274659

2,740 views
1 citation

Systematic Review

Published on 07 Dec 2023

Economic evaluation of breast MRI in screening - a systematic review and basic approach to cost-effectiveness analyses

in Breast Cancer

Fabian Tollens
Pascal A.T. Baltzer
Matthias F. Froelich
Clemens G. Kaiser

Frontiers in Oncology

doi 10.3389/fonc.2023.1292268

3,535 views
5 citations

Original Research

Published on 07 Dec 2023

Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma

in Cancer Molecular Targets and Therapeutics

Kyaw Zwar Myint
Mireia Sueca-Comes
Pamela Collier
Brinda Balasubramanian
Simran Venkatraman
John Gordan
Abed M. Zaitoun
Abhik Mukherjee
Arvind Arora
Noppadol Larbcharoensub

Frontiers in Oncology

doi 10.3389/fonc.2023.1184900

3,366 views
1 citation

Original Research

Published on 07 Dec 2023

Does surgery affect systemic immune response? a perioperative analysis of TGF-β, IL-8 and CD45RO

in Head and Neck Cancer

Leah Trumet
Jutta Ries
Niclas Ivenz
Philip Sobl
Falk Wehrhan
Rainer Lutz
Marco Kesting
Manuel Weber

Frontiers in Oncology

doi 10.3389/fonc.2023.1307956

1,686 views
2 citations

Retraction

Published on 07 Dec 2023

Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin

in Pharmacology of Anti-Cancer Drugs

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1337635

1,447 views

Retraction

Published on 07 Dec 2023

Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics

in Molecular and Cellular Oncology

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1343833

2,249 views

Original Research

Published on 07 Dec 2023

Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Justin B. Hackett
Nicholas Ramos
Stephen Barr
Madeline Bross
Nerissa T. Viola
Heather M. Gibson

Frontiers in Oncology

doi 10.3389/fonc.2023.1285117

3,012 views
1 citation

Original Research

Published on 07 Dec 2023

Primary squamous cell carcinoma of the pancreas: an update on a rare neoplasm from the SEER database

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jacob A. Ford
Arjun Bhatt
Rachel C. Kim
Michael Larkins
Aidan M. Burke

Frontiers in Oncology

doi 10.3389/fonc.2023.1272740

2,761 views
6 citations

Correction

Published on 07 Dec 2023

Expression of concern: MRE11 and UBR5 co-operate to suppress RNF168-mediated fusion of dysfunctional telomeres

in Neuro-Oncology and Neurosurgical Oncology

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1308554

1,311 views

Original Research

Published on 07 Dec 2023

Deep learning algorithm using bispectrum analysis energy feature maps based on ultrasound radiofrequency signals to detect breast cancer

in Breast Cancer

Qingmin Wang
Xiaohong Jia
Ting Luo
Jinhua Yu
Shujun Xia

Frontiers in Oncology

doi 10.3389/fonc.2023.1272427

1,975 views
2 citations

Review

Published on 07 Dec 2023

Hemangiosarcoma in dogs as a potential non-rodent animal model for drug discovery research of angiosarcoma in humans

in Molecular and Cellular Oncology

Kazuki Heishima
Naohiko Aketa
Mizuki Heishima
Asuka Kawachi

Frontiers in Oncology

doi 10.3389/fonc.2023.1250766

4,281 views

Review

Published on 07 Dec 2023

Inflammation-related prognostic markers in resected hepatocellular carcinoma

in Surgical Oncology

Fabio Giannone
Nevena Slovic
Patrick Pessaux
Catherine Schuster
Thomas F. Baumert
Joachim Lupberger

Frontiers in Oncology

doi 10.3389/fonc.2023.1267870

2,357 views
6 citations